Peri-operative high-dose v post-operative low dose steroid therapy in the management of biliary atresia: A preliminary report

Iranian Journal of Medical Sciences

Volumn 33, Issue 2, 2008, Pages 79-83

  Foroutan, H R ^a   Hosseini, A H ^a   Dehghani, S M ^a   Banani, S A ^a   Bahador, A ^a   Haghighat, M ^a   Imanieh, M H ^a   Jalli, R ^a   Gheisari, F ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biliary atresia; Cholangitis; Steroid

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; METHYLPREDNISOLONE; STEROID;

ARTICLE; BILE DUCT ATRESIA; BILIRUBIN BLOOD LEVEL; CHOLANGITIS; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; HUMAN; INFANT; JAUNDICE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PORTOENTEROSTOMY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; STEROID THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 48649089214     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sokol JR, Mack C, Narkewiez MR, Karrer FM. Pathogenesis and outcome of biliary atresia: current concepts. J Ped Gastroenterol Nutri 2003; 37: 4-21.
2. Chardot C, Carton M, Spire-Bendelac N, et al. Is the Kasai operation still indicated in children older than 3 months diagnosed with biliary atresia? J Pediatr 2001; 38: 224-8.
3. Lilly JR, Karrer FM, Hall RJ, et al. The surgery of biliary atresia. Ann Surg 1989; 210: 289-94.
4. Chardot C. Treatment for biliary atresia in 2003. J Pediatr Gastroenterol Nutr 2003; 37: 407-8.
5. Mowat AP, Davidson LL, Dick MC, et al. Earlier identification of biliary atresia and hepatobiliary disease: selective screening in the third week of life. Arch Dis Child 1995;72:90-2.
6. Kasai M, Suzuki S. A new operation for non-correctable biliary atresia: hepatic portoenterostomy. Shujyutsu 1959; 13: 733-9.
7. Otte JB, de Ville de Goyet J, Reding R, et al. Sequential treatment of biliary atresi with Kasai portoenterostomy and liver transplantation: French national study from 1986 to 1996. Hepatology 1994; 20: 41 S-48.
8. Ohi R, Hanamatsu M, Mochizuki I, et al. Progress in the treatment of biliary atresia. World J Surg 1985; 9:285-93.
9. Meyers RL, Book LS, O'Gorman MA, et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg 2003;38:406-11.
10. Dillon PW, Owings E, Cilley R, et al. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 2001; 36: 80-5.
11. Karrer FM, Lilly JR. Corticosteroid therapy in biliary atresia. J Pediatr Surg 1985; 20: 693-5.
12. Muraji T, Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg 1997; 32: 1103-6.
13. Kobayashi H, Yamataka A, Koga H, et al. Optimum prednisolone usage in patients with biliary atresia post portoenterostomy. J Pediatr Surg 2005; 40: 327-30.
14. Davenport M, Kerkar N, Mieli-Vergani G, et al. Biliary atresia: the King's College hospital experience (1974-1995). J Pediatr Surg 1997;32:479-85.
15. Mones RL, De Felice AR, Preud'Homme D. Use of neomycin as the prophylaxis against recurrent cholangitis after Kasai portoenterostomy. J Pediatr Surg 1994; 29: 422-4.
16. Balistreri WF. Bile acid therapy in pediatric hepatobiliary disease: The role of ursode-oxy cholic acid. J Pediatr Gastroenterol Nutr 1997; 24: 573-89.
17. Nakajo T, Hashizume K, Saeki M, Tsuchida Y. Intussusceptions-type antireflux valve in the Roux-En-Y loop to prevent ascending cholangitis after hepatic portojejunostomy. J Pediatr Surg 1990; 25: 311-4.
18. Haber BA, Russo P. Biliary atresia. Gastroentrol Clin North Am 2003; 32: 891-911.
19. Muraji T, Nishijima E, Higashimoto Y, Tsugawa C. Biliary atresia: current management and outcome. Tohoku J Exp Med 1997; 181:155-60.
20. Saeki M, Nakano M, Hagane K, Shimizu K. Effectiveness of intussusceptions antireflux valve to prevent ascending cholangitis after hepatic portoenterostomy in biliary atresi. J Pediatr Surg 1991; 26: 800-3.
21. Toyosake A, Okamato E, Okasava T, et al. Extensive dissection at the porta hepatic for biliary atresia. J Pediatr Surg 1994; 29: 896-9.
22. Wong KK, Fan AH, Lan LC, et al. Effective antibiotic regime for postoperative acute cholangitis in biliary atresia-an evolving scene. J Pediatr Surg 2004; 39: 1800-2.
23. Lünzmann K, Schweizer P. The influence of cholangitis on the prognosis of extra hepatic biliary atresia. Eur J Pediatr Surg 1999; 9:19-23.
24. Altman RP, Anderson KD. Surgical management of intractable cholangitis following successful Kasai procedure. J Pediatr Surg 1982; 17:894-900.
25. Meyers RL, Book LS, O'Gorman MA, et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia J Pediatr Surg 2003; 38: 406-11.
26. Escobar MA, Jay CL, Brooks RM, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 2006; 41: 99-103.
27. Hsieh CS, Wang PW, Lee SY, et al. Glucocorticoid pretreatment suppress chemokine expression and inflammatory cell infiltration in cholestatic rats receiving biliary intervention. J Pediatr Surg 2006; 41:1669-75.